Role of Polidocanol as Sclerosant in Treatment of Hemangiomas of Head and Neck Region
Article Sidebar
Main Article Content
Abstract
Introduction
Haemangiomas are common presentation in head and neck, prevalence being 60% followed by 25% and 15% respectively in trunk and limbs. This report studies the efficacy of Polidocanol as sclerosant in the treatment of heamangiomas in head and neck.
Materials and Methods
The two year prospective study conducted from January 2015 to December 2016 with Polidocanol as sclerosant on 55 patients attending the department of ENT. Intralesional injections of 3 % polidocanol were given at 2 week intervals.
Results
Out of 55 patients 15 cases did not follow up after the first dose, so results were calculated out of 40 patients. 12 patients showed complete regression & 15 showed regression to half the size. Thus 67.5 % patients showed acceptable results. There were no side effects except hyperpigmentation in 2 patients. There were no cases of recurrence during our study period.
Conclusion
Sclerotherapy is a promising method of treatment for haemangiomas of head and neck that may obviate the need for surgical intervention.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
References
Rodrigues Johann ACB, Ferreira Aguiar MC, Vieira Do Carmo MA, Gomez RS, Castro WH, Mesquita RA. Sclerotherapy of benign oral vascular lesion with ethanolamine oleate: an open clinical trial with 30 lesions. Oral surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology 2005; 100(5):579-84
Waner M, Suen JY, Dinehart S. Treatment of hemangiomas of the head and neck. Laryngoscope 1992; 102(10):1123-32
Agarwal S. Treatment of oral hemangioma with 3% sodium tetradecyl sulphate: a study of 20 cases. Indian Journal of Otolaryngology and Head and Neck Surgery 2012; 64(3):205-7
Minkow B, Loufer D, Gutman D. Treatment of oral hemangiomas with local sclerosing agents. International Journal of Oral Surgery 1979; 8(1):18-21
Selim H, Selim A, Khachemoune A, Metwally SAFA. Use of sclerosing agent in the management of oral and perioral hemangiomas: review and case reports. Medical Science Monitor 2007; 13(9): CS114-9
Winter H, Drager E, Sterry W. Slcerotherapy for treatment of hemangiomas. Dermatologic Surgery 2000; 26(2):105-8
Cardoso CL, Da Silva LMP, Fernandes R, Rocha JF, Goncales ES, Ferreira O Junior, De Assis Taveira LA. Surgical approach of intraoral hemangioma. Odontologia Clinico-Cienttifica 2010; 9(2):177-80
C. Bonet-Coloma, I. Minguez-Martinez, C. Palma-Carrio, S. Galan-Gil, M. Penarrocha-Diago, J. M. Minguez-Sanz. Clinical characteristics, treatment and outcome of 28 oral hemangiomas in pediatric patients. Medicina Oral, Patologia Oral Cirugia Bucal 2011; 16(1):E19-E22
Zanettini I, Zanettini RN, Gollo G. Sclerotherapy as an alternative treatment of oral vascular lesions. Revista de Clinica e Pesquisa Odontologica 2005; 2:119-26
S.Bhadoria S, R. Saxena R, A.Lavania A. Management of haemangioma neck using sclerosing agent- a case report. Journal of College of Medical Sciences-Nepal 2012; 8(1):56-9
Patel N, Prajapati BJ, Palas A, Shah HR, Meel AM, Dharajia D. Sclerotherapy for Haemangioma of Oral Cavity. Indian Journal of Applied Research 2015; 5(6):649
Singh R, Agarwal S, Sinha ON, Gaur S: A case report- Inj. Polidocanol in Haemangioma of Tongue. Scholars Journal of Applied Medical Sciences (SJAMS) 2016; 4(7):2433-5
Abdyli RA, Abdyli Y, Perjuci F, Gashi A, Agani Z, Ahmedi J. Sclerotherapy of Intraoral Superficial Hemangioma. Case Reports in Dentristry 2016, Article ID 4320102 (http://dx.doi.org/10.1155/2016/4320102)
Crisan BV, Baciut M, Baciut G, Campian RS, Crisan L. Laser Treatment in Oral and Maxillofacial Hemangioma and Vascular Malformations. Timisoara Medical Journal 2010; 60(1):34-8
Witman PM, Wagner AM, Scherer K, Waner M, Frieden IJ. Complications following pulsed dye laser treatment of superficial hemangiomas. Lasers in Surgery and Medicine 2006; 38(2):116-23.